90 related articles for article (PubMed ID: 1375300)
41. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
42. Glomerular mesangium. Analysis of the increased activity observed in experimental acute aminonucleoside nephrosis in the rat.
Grond J; Elema JD
Lab Invest; 1981 Nov; 45(5):400-9. PubMed ID: 7300251
[TBL] [Abstract][Full Text] [Related]
43. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats.
Pawluczyk IZ; Najafabadi MG; Brown JR; Bevington A; Topham PS
Lab Invest; 2015 Sep; 95(9):1019-28. PubMed ID: 26121320
[TBL] [Abstract][Full Text] [Related]
44. Effects of celecoxib and nordihydroguaiaretic acid on puromycin aminonucleoside-induced nephrosis in the rat.
Lee DW; Kwak IS; Lee SB; Song SH; Seong EY; Chung HC; Yang BY; Lee MY; Sol MY
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S183-8. PubMed ID: 19194550
[TBL] [Abstract][Full Text] [Related]
45. Unaltered anionic sites of glomerular basement membrane in aminonucleoside nephrosis.
Kanwar YS; Jakubowski ML
Kidney Int; 1984 Apr; 25(4):613-8. PubMed ID: 6482165
[TBL] [Abstract][Full Text] [Related]
46. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.
Suzuki A; Ito T; Imai E; Yamato M; Iwatani H; Kawachi H; Hori M
J Am Soc Nephrol; 2003 Apr; 14(4):981-91. PubMed ID: 12660332
[TBL] [Abstract][Full Text] [Related]
47. Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats.
Kawamorita Y; Shiraishi T; Tamura Y; Kumagai T; Shibata S; Fujigaki Y; Hosoyamada M; Nakagawa T; Uchida S
Physiol Rep; 2017 Aug; 5(15):. PubMed ID: 28774949
[TBL] [Abstract][Full Text] [Related]
48. Yi Qi Qing Re Gao formula ameliorates puromycin aminonucleoside-induced nephrosis by suppressing inflammation and apoptosis.
Wen Y; Zhan Y; Liu H; Zhao T; Yang L; Zhang H; Dong X; Li P
BMC Complement Altern Med; 2015 May; 15():155. PubMed ID: 26014479
[TBL] [Abstract][Full Text] [Related]
49. Effect of the in vivo catalase inhibition on aminonucleoside nephrosis.
Pedraza-Chaverri J; Granados-Silvestre MD; Medina-Campos ON; Hernández-Pando R
Free Radic Biol Med; 1999 Aug; 27(3-4):245-53. PubMed ID: 10468195
[TBL] [Abstract][Full Text] [Related]
50. Effect of grape seed extract on puromycin-aminonucleoside-induced nephrosis in rats.
Mattoo TK; Kovacevic L
Pediatr Nephrol; 2003 Sep; 18(9):872-7. PubMed ID: 12836089
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of a mitochondrion-targeting agent for reducing the level of urinary protein in rats with puromycin aminonucleoside-induced minimal-change nephrotic syndrome.
Fujii Y; Matsumura H; Yamazaki S; Shirasu A; Nakakura H; Ogihara T; Ashida A
PLoS One; 2020; 15(1):e0227414. PubMed ID: 31905213
[TBL] [Abstract][Full Text] [Related]
52. Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis.
Olbricht CJ; Cannon JK; Tisher CC
Kidney Int; 1987 Sep; 32(3):354-61. PubMed ID: 3669494
[TBL] [Abstract][Full Text] [Related]
53. Effects of KW-3902, an adenosine A1-receptor antagonist, on ascites volume in puromycin aminonucleoside (PAN)-induced nephrotic rats.
Kusaka H; Nagashima K; Karasawa A
Jpn J Pharmacol; 1995 Jun; 68(2):213-6. PubMed ID: 7563979
[TBL] [Abstract][Full Text] [Related]
54. Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
Sagae Y; Matsumoto Y; Unno K
J Pharmacobiodyn; 1983 Jul; 6(7):475-80. PubMed ID: 6358456
[TBL] [Abstract][Full Text] [Related]
55. Effect of albumin administration on L-tryptophan levels in the serum and tissues of rats with puromycin aminonucleoside-induced nephrosis.
Sasaki E; Ohta Y; Ishiguro I
Adv Exp Med Biol; 1999; 467():341-6. PubMed ID: 10721075
[TBL] [Abstract][Full Text] [Related]
56. Oxidative stress in a rat model of nephrosis can be quantified by electron spin resonance.
Nakakura H; Ashida A; Hirano K; Tamai H
Pediatr Nephrol; 2004 Mar; 19(3):266-70. PubMed ID: 14714169
[TBL] [Abstract][Full Text] [Related]
57. Identification by an EPR technique of decreased mitochondrial reducing activity in puromycin aminonucleoside-induced nephrosis.
Ueda A; Nagase S; Yokoyama H; Tada M; Ohya H; Kamada H; Hirayama A; Koyama A
Free Radic Biol Med; 2002 Oct; 33(8):1082-8. PubMed ID: 12374619
[TBL] [Abstract][Full Text] [Related]
58. Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria.
Thakur V; Walker PD; Shah SV
Kidney Int; 1988 Oct; 34(4):494-9. PubMed ID: 2848972
[TBL] [Abstract][Full Text] [Related]
59. Effects of cyclosporine on puromycin aminonucleoside-induced nephrotic rats.
Shibasaki T; Matsuda H; Nakano H; Matsumoto H; Miyahara T
J Chemother; 1989 Jun; 1(3):211-5. PubMed ID: 2795127
[TBL] [Abstract][Full Text] [Related]
60. Effect of tacrolimus on the expression of Park7 in glomerular podocytes injured by puromycin aminonucleoside.
Tan JJ; Yu SY; Zhang Y; Hao ZH; Yu L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Sept 15; 23(9):951-958. PubMed ID: 34535212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
